Product NDC: | 0409-1761 |
Proprietary Name: | Marcaine Spinal |
Non Proprietary Name: | BUPIVACAINE HYDROCHLORIDE |
Active Ingredient(s): | 7.5 mg/mL & nbsp; BUPIVACAINE HYDROCHLORIDE |
Administration Route(s): | SUBARACHNOID |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-1761 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018692 |
Marketing Category: | NDA |
Start Marketing Date: | 20100312 |
Package NDC: | 0409-1761-62 |
Package Description: | 800 AMPULE in 1 CASE (0409-1761-62) > 2 mL in 1 AMPULE |
NDC Code | 0409-1761-62 |
Proprietary Name | Marcaine Spinal |
Package Description | 800 AMPULE in 1 CASE (0409-1761-62) > 2 mL in 1 AMPULE |
Product NDC | 0409-1761 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | BUPIVACAINE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBARACHNOID |
Start Marketing Date | 20100312 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | BUPIVACAINE HYDROCHLORIDE |
Strength Number | 7.5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] |